Mr. Huang Junquan
Chief Operating Officer
As Chief Operating Officer of Biolidics, Mr. Huang Junquan is responsible for overseeing and managing our operations.
From 2006 to 2008, Mr. Huang Junquan was a human islet isolation coordinator at St Vincent’s Institute in Australia, where he led a team of doctors and scientists in successfully isolating islets in a cGMP facility. He also coordinated the first human islet transplantation in Victoria, Australia. From 2008 to 2010, Mr. Huang Junquan was a senior officer of the Biomedical Research Council at the Agency for Science, Technology and Research (“A*STAR”), overseeing budget utilisation and KPI monitoring of research institutes. He assisted in planning and strategising Singapore’s research landscape, as well as A*STAR’s funding mechanisms over four financial years.
From 2010 to 2011, he was appointed as a regulatory specialist with the Health Sciences Authority (“HSA”) medical device branch, where he performed pre-market evaluations of high-risk medical devices to meet safety and performance standards. Mr. Huang Junquan also assisted in developing Singapore’s medical devices standards and HSA guidance documents to ensure device compliance. From 2011 to 2018, Mr. Huang Junquan held several positions within our Company, including Manager (Product Development), Senior Manager (Product Development), Director (Product Development) and Senior Director (Strategic Development), before he was appointed as Chief Operating Officer in August 2018.
Mr. Huang Junquan obtained his Bachelor of Biomedical Science in 2005 and his Bachelor of Science (Degree with Honours) in 2006 from the University of Melbourne.
Mr. Tan Wei Chee
As Financial Controller of Biolidics, Mr. Tan Wei Chee is responsible for overseeing and managing our strategic and day-to-day activities, including financial costing, management accounting and corporate human resource functions. He has been with our Company since January 2016.
From 2009 to 2015, he was an audit manager at Deloitte & Touche LLP, Singapore, where he was responsible for the application of International Financial Reporting Standards and Singapore Financial Reporting Standards. During his tenure, he led teams and managed resources in audit engagements to ensure proper and timely head-office reporting and statutory reporting. He also identified corporate governance flaws and offered best practice proposals, and ensured compliance to clients’ internal controls and regulatory requirements.
Mr. Tan Wei Chee obtained his Degree of Bachelor of Accountancy from Nanyang Technological University in 2009. He qualified as a Chartered Accountant of Singapore and was admitted as a Member of the Institute of Singapore Chartered Accountants in 2014.